Background: Sulfur-containing compounds represent an important class of chemical compounds due to their wide range of biological and pharmaceutical properties. Moreover, sulfur-containing compounds may be applied in other fields, such as biological, organic, and materials chemistry. Several studies on the activities of sulfur compounds have already proven their anti-inflammatory properties and use to treat diseases, such as Alzheimer’s, Parkinson’s, and HIV. Moreover, examples of sulfur-containing compounds include dapsone, quetiapine, penicillin, probucol, and nelfinavir, which are important drugs with known activities. Objective: This review will focus on the synthesis and application of some sulfur-containing compounds used to treat several diseases, as well as promising new drug candidates. Results: Due to the variety of compounds containing C-S bonds, we have reviewed the different synthetic routes used toward the synthesis of sulfur-containing drugs and other compounds.
The palladium-catalyzed Suzuki–Miyaura cross-coupling reaction is one of the most important and efficient reactions to prepare a variety of organic compounds, including biaryls. Despite the overwhelming number of reports related to this topic, some methodological difficulties persist in terms of catalyst handling, recovery, and reuse, as well as the reaction media. This work reports the rational design of new, efficient, cost-effective, and reusable palladium catalysts supported on synthetic talc for the Suzuki–Miyaura reaction. From the results, key points were identified: both designed catalysts accelerated the reaction in EtOH and an open-flask setup, affording moderate to excellent yields within a short time (e.g., 30 min) even for deactivated aryl halides; the protocol can be applied to a great number of both cross-coupling partners, showing an excellent functional group tolerance; the catalysts can be recovered and reused without significant loss of activity. This protocol was used for the synthesis of a precursor of angiotensin II inhibitors such as valsartan, losartan, irbesartan, and telmisartan.
A new and effective palladium catalyst supported on a magnesium organosilicate for application in the Heck reaction is presented. A group of compounds comprising 22 examples were synthesized in moderate to high yields (up to 99%) within a short time. The palladium supported on magnesium organosilicate catalyst was characterized as an amorphous solid by SEM, containing around 33% of palladium inside the solid, and even with this low quantity of palladium, the catalyst was very efficient in the Heck reaction. Besides, based on the Scherrer equation, the crystallite size of the synthesized palladium nanoparticles was ultrasmall (around 1.3 nm). This strategy is a simple and efficient route for the formation of C–C bonds via the Heck cross-coupling reaction.
1 January 2026 in Journal of the Brazilian Chemical Society
The synthesis of sulfur-linked glycosides, such as S-glycosides or S-glycoconjugates, has been extensively explored due to their roles as valuable tools in various biological studies. These compounds can act as glycosidase inhibitors, antibacterial agents, antitumor agents, and more. 1-Thioglycosides are characterized by a sulfur atom bonded to the anomeric position and are rare in nature. Besides their biological and pharmaceutical significance, thioglycosides serve as key substrates for the synthesis of other glycosides (O-, N-, and C-glycosides), glycoconjugates, glycoproteins, and polysaccharides. The growing interest in biologically active S-glycosides stems from their enhanced stability compared to O-glycosides, making them less prone to enzymatic hydrolysis and chemical degradation. This stability underpins their use as enzyme inhibitors and their presence in various drugs and bioactive natural products. Consequently, the development of efficient synthetic methodologies for functionalized 1-thioglycosides remains a critical focus in medicinal and organic chemistry research. This review focuses on recent advances in the synthetic methodologies for functionalized 1-thioglycosides, highlighting key strategies and their potential applications in medicinal chemistry.